Literature DB >> 26674561

Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.

Ariela Noy1, Shelly Y Lensing2, Page C Moore2, Neel Gupta3, David Aboulafia4, Richard Ambinder5, Robert Baiocchi6, Bruce J Dezube7, David Henry8, Lawrence Kaplan9, Alexandra M Levine10, Ronald Mitsuyasu11, Lee Ratner12, Erin Reid13, Scot Remick14, Joseph Sparano15, Dimitrios Tzachanis7, William Wachsman13, Amy Chadburn16.   

Abstract

Entities:  

Keywords:  HIV; highly active antiretroviral therapy; lymphoma; plasmablastic

Mesh：

Substances：

Year:  2015        PMID： 26674561      PMCID： PMC4899288          DOI： 10.3109/10428194.2015.1113281

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  16 in total

1.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Authors:  R I Fisher; E R Gaynor; S Dahlberg; M M Oken; T M Grogan; E M Mize; J H Glick; C A Coltman; T P Miller
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

Review 2.  The biology and treatment of plasmablastic lymphoma.

Authors:  Jorge J Castillo; Michele Bibas; Roberto N Miranda
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

3.  Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience.

Authors:  Chiara Cattaneo; Alessandro Re; Marco Ungari; Annalisa Peli; Salvatore Casari; Filippo Castelnuovo; Simona Fisogni; Silvia Lonardi; Vilma Pellegrini; Marta Petullà; Fabio Facchetti; Giuseppe Rossi
Journal:  Leuk Lymphoma       Date:  2014-06-16

4.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

5.  Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.

Authors:  Jorge J Castillo; Michael Furman; Brady E Beltrán; Michele Bibas; Mark Bower; Weina Chen; José L Díez-Martín; Jane J Liu; Roberto N Miranda; Silvia Montoto; Nahid M Nanaji; José-Tomás Navarro; Adam C Seegmiller; Julie M Vose
Journal:  Cancer       Date:  2012-04-17       Impact factor: 6.860

6.  Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.

Authors:  Richard F Little; Stefania Pittaluga; Nicole Grant; Seth M Steinberg; Mark F Kavlick; Hiroaki Mitsuya; Genoveffa Franchini; Martin Gutierrez; Mark Raffeld; Elaine S Jaffe; Gene Shearer; Robert Yarchoan; Wyndham H Wilson
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

7.  Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).

Authors:  Joseph A Sparano; Sandra Lee; Michael G Chen; Tipu Nazeer; Avi Einzig; Richard F Ambinder; David H Henry; Jane Manalo; Tianhong Li; Jamie H Von Roenn
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

Review 8.  HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.

Authors:  Jorge Castillo; Liron Pantanowitz; Bruce J Dezube
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

9.  AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.

Authors:  Ariela Noy; Jeannette Y Lee; Ethel Cesarman; Richard Ambinder; Robert Baiocchi; Erin Reid; Lee Ratner; Nina Wagner-Johnston; Lawrence Kaplan
Journal:  Blood       Date:  2015-05-08       Impact factor: 22.113

10.  Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.

Authors:  Sanam Loghavi; Khaled Alayed; Tariq N Aladily; Zhuang Zuo; Siok-Bian Ng; Guilin Tang; Shimin Hu; C Cameron Yin; Roberto N Miranda; L Jeffrey Medeiros; Joseph D Khoury
Journal:  J Hematol Oncol       Date:  2015-06-10       Impact factor: 17.388
View more
  12 in total

Review 1.  HIV-Associated Cancers and Related Diseases.

Authors:  Robert Yarchoan; Thomas S Uldrick
Journal:  N Engl J Med       Date:  2018-03-15       Impact factor: 91.245

2.  Primary central nervous system plasmablastic lymphoma in an HIV-positive patient.

Authors:  Ruben Rhoades; Jerald Gong; Neil Palmisiano; Onder Alpdogan
Journal:  BMJ Case Rep       Date:  2019-03-14

Review 3.  Optimizing treatment of HIV-associated lymphoma.

Authors:  Ariela Noy
Journal:  Blood       Date:  2019-10-24       Impact factor: 22.113

4.  Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.

Authors:  Laura Pasqualucci; Raul Rabadan; Pascale Willem; Zhaoqi Liu; Ioan Filip; Karen Gomez; Dewaldt Engelbrecht; Shabnum Meer; Pooja N Lalloo; Pareen Patel; Yvonne Perner; Junfei Zhao; Jiguang Wang
Journal:  Blood Cancer Discov       Date:  2020-07

Review 5.  HIV Lymphoma and Burkitts Lymphoma.

Authors:  Ariela Noy
Journal:  Cancer J       Date:  2020 May/Jun       Impact factor: 2.074

6.  Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.

Authors:  Chunmeng Rong; Lixia Sheng; An Wu; Ye Sun; Guifang Ouyang
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

7.  A True Mimicker to Plasmacytoma Clinically, Radiologically, and Pathologically - A Rare Case Report.

Authors:  Shino P Ashly; Anu C Thomas; Sajeev S Vadakkedam
Journal:  Asian J Neurosurg       Date:  2021-12-18

8.  Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers.

Authors:  Lilie L Lin; David S Lakomy; Elizabeth Y Chiao; Robert M Strother; Meg Wirth; Ethel Cesarman; Margaret Borok; Naftali Busakhala; Carla J Chibwesha; Lameck Chinula; Ntokozo Ndlovu; Jackson Orem; Warren Phipps; Vikash Sewram; Samantha L Vogt; Joseph A Sparano; Ronald T Mitsuyasu; Susan E Krown; Satish Gopal
Journal:  JCO Glob Oncol       Date:  2020-07

9.  Plasmablastic lymphoma masquerading solitary plasmacytoma in an immunocompetent patient.

Authors:  Rodrigo Diaz; Julan Amalaseelan; Louise Imlay-Gillespie
Journal:  BMJ Case Rep       Date:  2018-10-21

10.  Perianal Plasmablastic Lymphoma Masquerading as a Buschke-Löwenstein-like Tumour in an HIV-infected Patient with Recurrent Anal Condyloma.

Authors:  Xavier Rivera Rivera; Joshua Baalwa
Journal:  Eur J Case Rep Intern Med       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.